BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cytovance Biologics Inc. Receives 2012 CMO Leadership Award as a Category Leader for Reliability


9/18/2012 10:22:47 AM

OKLAHOMA CITY, OK--(Marketwire - September 18, 2012) -

Cytovance Biologics, a leading full-service contract manufacturer of mammalian and microbial biologics, announced today its receipt of the 2012 CMO Leadership Award as a category leader for Reliability.

The CMO Leadership Award is based on industry research conducted by Nice Insight and presented by Life Science Leader Magazine. Cytovance scored a 75% customer perception (CP) rating by Nice in Q4 -- an increase from Q3.

According to Life Science Leader, the awards were developed to better serve pharmaceutical and biopharmaceutical executives in their vetting process of CMOs. The awards represent the opinions of over 3,000 pharmaceutical and biopharmaceutical executives and only CMOs who were in the top 20% of each perception category qualified for a CMO Leadership Award.

"We are honored to be recognized by our clients as a Liquid Dose Manufacturing leader for Reliability," stated Darren Head, President and Chief Executive Officer of the company. "Cytovance Biologics takes pride in being a reliable, value-added partner with our clients in providing integral pathways of converting today's novel protein discoveries into future life saving therapies. This award is possible thanks to our highly experienced employees that consistently demonstrate commitment to service. We accept this award as a testament to the dedication and hard work of many within our remarkable company."

Cytovance was recognized as a category leader in 2011 for Regulatory and Productivity.

About Cytovance® Biologics

Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services from its Oklahoma City state-of-the-art facilities.

Learn more about Cytovance Biologics at www.cytovance.com.


Cytovance Media Contact
Jodie Gutkowski
Marketing/Communications Manager
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES